Largest ever UK study reveals stark ethnic and social inequalities in lung cancer diagnosis
8 November 2024
Research from Professor Julia Hippisley-Cox shows Bangladeshi men face highest risks, while people in deprived areas are twice as likely to develop lung cancer compared to affluent areas, with important implications for NHS screening.
OxCODE researchers at the Early Detection of Cancer Conference 2024
25 October 2024
Oxford’s early detection research was featured at this annual event.
Oxford Liver Cancer Centre of Excellence (OLivE) launched
24 October 2024
Oxford Cancer announces the launch of the Oxford LIVer cancer centre of Excellence (OLivE) to improve outcomes for liver cancer patients.
OxCODE funding scheme awards 2024
22 October 2024
Congratulations to I-Jun Lau, Dimitris Vavoulis and their collaborators who have been awarded funding in the fifth round of the OxCODE Funding Scheme.
UK cancer registry data is as accurate and timely as on-site trial data, new study shows
15 October 2024
OxCODE researchers report that cancer data collected by national cancer registries is comparable to the data gathered directly by researchers in clinical studies. This could make cancer research much easier and less expensive in the future.
New biomarker and therapeutic target identified for blood cancers
10 October 2024
Research from Oxford has revealed a protein called galectin-1 as a key marker for disease progression and as a promising therapeutic target for patients with myeloproliferative neoplasms
Funding to create world's first ovarian cancer prevention vaccine
4 October 2024
Researchers from Oxford have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.
OxCODE travel award winner featured by Cancer Research UK
12 September 2024
Dr Zhe Huang talks about his work on investigating the proteomic profiles of prostate cancer, his OxCODE-funded trip to Boston and the story behind his early career
Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome
10 September 2024
Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.
Senior Fellowship awarded to Associate Professor Beth Psaila
28 August 2024
Congratulations to OxCODE Operational Group Member Beth Psaila, who has been awarded a Senior Fellowship funded by Cancer Research UK in partnership with Rosetrees Trust.
Identifying early symptoms associated with a diagnosis of childhood, adolescent and young adult cancers
26 July 2024
Dr Defne Saatci and Professor Julia Hippisley-Cox aim to improve early diagnosis of cancers in this age group through earlier recognition of signs and symptoms.
Expansion of Oxford-led clinical study evaluating AI software for diagnosing prostate cancer
22 July 2024
Oxford University Hospitals (OUH) NHS Foundation Trust, North Bristol NHS Trust, and University Hospitals Coventry and Warwickshire (UHCW) NHS Trust are evaluating a new Artificial Intelligence (AI) diagnostic system that could help improve prostate cancer diagnosis.
Oxford hosts industry event on cancer precision prevention trials
17 July 2024
Professor Sarah Blagden led a panel discussion focused on the opportunities of cancer precision prevention.
Featured interview with GambitBio CEO and OxCODE researcher
8 July 2024
GambitBio is developing an at-home lateral flow test to screen for the most common cancers, empowering people to take control of their health and reduce the number of cancer-related deaths. Cancer Research Horizons recently interviewed CEO, Tiffany Ma, who co-founded the venture while completing her DPhil at the University of Oxford.
OxCODE researchers at the inaugural Cancer Prevention Research conference 2024
4 July 2024
Over 20 Oxford researchers engaged with over 350 attendees from all over the world at a truly interdisciplinary cancer prevention conference.
OxCODE travel awards 2024
20 June 2024
Congratulations to Jingfei Cheng, Holly Eggington, Yi-Jhih Huang, Zhe Huang and Joshua Moore who have been awarded OxCODE funds to attend this year’s major cancer prevention and early detection conferences.
Highlights from CRUK’s Early Diagnosis Conference 2024
18 June 2024
OxCODE primary care researchers recently attended this year's Cancer Research UK Early Diagnosis Conference in Birmingham, which focused on the theme 'Driving Evidence into Practice'.
Blood proteins may be able to predict risk of cancer more than seven years before it is diagnosed
15 May 2024
Proteins linked to cancer can start appearing in people’s blood more than seven years before they’re diagnosed. In the future, it’s possible doctors could use these early warning signs to find and treat cancer much earlier than they’re able to today.
Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer
8 May 2024
The new method could help people with new-onset diabetes at high-risk of developing pancreatic cancer to be identified more accurately so that they can be monitored.
Oxford lung cancer early detection trial reaches 400 participants
8 April 2024
The SCOOT study seeks current and former smokers across England to provide blood samples for ongoing research aiming to improve lung cancer diagnosis.